All stocks / HEPA
Hepion Pharmaceuticals, Inc. HEPA
Hepion Pharmaceuticals (HEPA): shares outstanding up 976% in a year, convertible notes mentioned in an 8-K in September 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- HEPION PHARMACEUTICALS INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 16
- Website
- hepionpharma.com
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($8,277,850)
It spends more than it earns
Under strainThe company lost $8.3 million in the year. It reported no sales.
- Cash and cash equivalents
- $1,828,062
- Net cash used in operating activities
- ($3,271,520)
The cash could run out soon
Under strainIt had $1.8 million in the bank and used about $272,627 a month. At that pace the money lasts about 7 months unless it borrows or sells more shares.
- Total assets
- $3,069,952
- Total liabilities
- $402,405
It owns more than it owes
SteadyEverything the company owns adds up to $3.1 million. Its debts and unpaid bills add up to $402,405. That is about $0.13 owed for every $1 owned.
What this adds up to
2 of 3 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.
Signals
Shares outstanding rose from 11,620,317 (2025-11-12) to 125,074,297 (2026-11-08), up 976%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 98,374,297 shares as of 2026-11-08: 125,074,297 outstanding minus 26,700,000 held by 6 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
8-K filed 2026-09-08 mentions: convertible note.
Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about HEPA
Does HEPA file reports with the SEC?
Yes. Hepion Pharmaceuticals files with the SEC under company number 0001583771. The most recent filing we hold is a 10-Q dated 2026-11-16.
Source recordHow many HEPA shares are outstanding?
125,074,297 shares as of 2026-11-08, as reported to the SEC. That is up 976% from 11,620,317 on 2025-11-12.
Source recordHas HEPA filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Who runs Hepion Pharmaceuticals?
Officers named in its insider filings: Sireesh Appajosyula (Chief Executive Officer), Chase LoPriore (VP, Corp. Dev.) and Vincent S LoPriore (Executive Chairman).
Source recordIs Hepion Pharmaceuticals making money?
The company lost $8.3 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record